Research Articles
Genome Editing and Silencing: The Fourth Annual BRDS and the Future of Precision Medicine
Exploring the latest advances in genome editing technologies presented at the fourth annual Biopharmaceutical Research and Development Symposium and their impact on precision medicine.
Unlocking the Genetic Code to Make Chemotherapy Safer
Exploring how pharmacogenetics can reduce methotrexate toxicity in adult acute lymphoblastic leukemia treatment through gene polymorphism analysis.
Nature's Time Machine: How Long-Term Studies Are Unlocking Evolution's Secrets
Discover how long-term evolutionary studies are revolutionizing our understanding of how life evolves, from Galápagos finches to laboratory experiments on multicellularity.
Breaking Through the Nuclear Barrier: The Golden Key to Gene Delivery
Revolutionary gene delivery system using α-synuclein-gold nanoparticle conjugates enables cell-division-independent DNA expression with unprecedented speed and safety.
The Fishy Connection: How an Alzheimer's Gene Controls Skin Pigmentation
Discover how zebrafish research revealed the surprising connection between Alzheimer's gene PRESENILIN 2 and skin pigmentation through CRISPR experiments.
Sewage Sleuths: Tracking Invisible Viruses in Iraq's Waterways
Discover how scientists in Diyala, Iraq are using wastewater analysis to track Astrovirus and Norovirus through molecular detection and phylogenetic analysis.
Cracking the Genome's Second Code: How Regulatory Codewords Shape Life
Discover how regulatory codewords, the genome's second code, control gene expression and shape biological development through flexible regulatory mechanisms.
The DNA Deluge: Is Next-Gen Sequencing a Breeder's Gold Mine or Data Tsunami?
How next-generation sequencing technology is reshaping the future of our food, one billion DNA letters at a time.
Life at the Edge: Unraveling the Mysteries of Antarctica's Ecosystems
Explore the fascinating world of Antarctic ecosystems, their unique biodiversity, survival adaptations, and the threats they face in a changing climate.
Gilead's Gene-Editing Gambit: How Big Pharma is Betting on CRISPR 2.0
Explore Gilead's strategic partnerships in gene editing and targeted protein degradation technologies that are reshaping the future of medicine.